Prostap injection and weight loss: separating fact from assumption

The misconception: that Prostap causes weight loss by design

Prostap is a gonadotrophin-releasing hormone (GnRH) agonist. Its job is to suppress the production of oestrogen or testosterone, depending on the condition being treated. Weight changes are a recognised consequence of that hormonal shift, but they tend to go in the opposite direction to what people searching this topic might hope for.

In men receiving Prostap for prostate cancer, androgen deprivation commonly increases body fat, particularly visceral (abdominal) fat, while reducing lean muscle mass. In women using it for endometriosis or fibroid management, the oestrogen suppression it causes can produce similar body-composition shifts. Neither outcome is intentional weight management. It is a side effect, one that many patients find difficult and that their clinical team should know about.

The short version: Prostap is not in any weight-loss medicine category, does not appear on any UK licensing document as a treatment for obesity, and there is no clinical evidence supporting its use for that purpose. The NHS overview of obesity treatments does not mention leuprorelin or GnRH agonists in this context at all.

What the hormonal changes actually do to the body's weight regulation

Oestrogen and testosterone both play roles in how the body distributes and uses fat. When Prostap drives these hormones down to near-menopausal or castrate levels, the metabolic picture shifts. Resting metabolic rate can fall. Appetite signalling changes. The body tends to store more fat and hold less muscle, a combination that raises total weight for many patients even when calorie intake stays the same.

For people already managing their weight, this can be genuinely frustrating. If you are on Prostap and finding that the scales are moving in the wrong direction despite your best efforts, that is a recognised clinical phenomenon worth raising with your doctor. It is not something to try to offset with an unlicensed injection found online.

The good news is that the medicines which are designed for weight management work through entirely different mechanisms. Tirzepatide, for example, acts on GIP and GLP-1 receptors to reduce appetite and slow gastric emptying, a biological pathway quite distinct from anything Prostap touches. You can read about how these injections compare in our overview of the pros and cons of weight-loss injections.

Which injections are licensed for weight loss in the UK, and how to access them

Two injectable medicines hold UK marketing authorisations specifically for weight management in adults. Mounjaro (tirzepatide), made by Eli Lilly, is licensed for adults with a BMI of 30 or above, or 27 and above with at least one weight-related health condition such as high blood pressure, type 2 diabetes or sleep apnoea. Wegovy (semaglutide), made by Novo Nordisk, carries a similar licence. Both are prescription-only medicines, a prescriber reviews your health picture and decides whether either is appropriate for you.

Neither can be legally dispensed without that prescription. Any seller offering these medicines without requiring a clinical assessment is operating outside the law, and the MHRA has repeatedly warned about counterfeit pens that have caused serious harm, some found to contain insulin rather than the labelled medicine. The right route is a registered pharmacy whose prescribers carry out a real assessment, every time.

If you are already on Prostap and you are also wondering about your weight, that is a conversation your GP or specialist is best placed to lead, because your underlying condition and current treatment will shape what is medically appropriate. For people not on any other treatment whose main concern is weight, our guide to weight loss injections explains the licensed options in detail, and the cost context page covers what private treatment typically involves.

If weight management is your main concern, here is where to start

A prescription for a licensed weight-management medicine begins with a proper clinical consultation. At nume, a GPhC-registered Independent Prescriber reads your answers the same day, a real clinician, not automated software. If treatment is clinically suitable, your pen is dispatched the same day you order before 12pm, arriving via tracked DPD the next working day in plain packaging. Keeping it in the fridge door when you get home is the easy part.

What is not included in that process is any shortcut around clinical oversight. There are no discount codes, no auto-renewals, no subscription that bypasses a review. Every repeat order gets its own clinical assessment, because bodies change and prescribers need to know about it. Our clinical team takes that seriously, including when patients come to us managing complex underlying conditions alongside weight concerns.

People living with conditions like endometriosis or prostate cancer, where Prostap is commonly used, often have additional weight-related health considerations that sit firmly within a specialist's remit. If you are exploring whether a weight loss injection could be suitable for your situation, factors such as a weight-related metabolic condition can affect eligibility and what a prescriber recommends. The consultation is the right place to lay all of that out, and it is free. You can also find out more about how an m injection for weight loss works and what the clinical criteria look like before you begin, or explore our weight loss injection r page if you want to understand how specific options are categorised and reviewed.